Table 4.
Betahistine |
Piracetam |
Ginkgo biloba |
||||
---|---|---|---|---|---|---|
Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | |
Ménière’s disease n (%) (n = 672) | 595 (94.9) | 453 (72.3) | 106 (17.0) | 69 (11.1) | 72 (11.4) | 48 (7.7) |
BPPV n (%) (n = 1,091) | 933 (85.6) | 724 (66.3) | 174 (15.9) | 119 (10.9) | 125 (11.4) | 70 (6.4) |
Other vertigo n (%) (n = 1,512) | 1,377 (91.1) | 1,112 (73.6) | 435 (28.7) | 263 (17.4) | 170 (11.3) | 139 (9.2) |
Peripheral vestibular vertigo n (%) (n = 832) | 763 (91.7) | 627 (75.4) | 170 (20.4) | 126 (15.1) | 69 (8.3) | 58 (7.0) |